- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
What do you get from participation with the president, if the president doesn't represent the country's values?
Cramer's outlook on drug stocks.
Despite a Phase 3 stumble, BMY stock is holding up.
Previously studies already showed improvement from use of Exelixis's Cabometyx over Pfizer's Sutent in treating kidney cancer patients.